(PharmaNewsWire.Com, March 14, 2019 ) The report provides a detailed overview on the Global Artificial Pancreas Device System Market with overview and forecast of the Global Artificial Pancreas Device System Market based on type, and geography. It also provides market size and forecast till 2025 for overall Artificial Pancreas Device System Market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America.
Artificial pancreas device system are the devices that closely copy the glucose regulating function of fit pancreas. The device not only monitors the glucose levels in the body, it also automatically adjusts the distribution of insulin to reduce high blood glucose levels and lowers the incidence of low blood glucose with less or no input from the patient.
The “Global Artificial Pancreas Device System Market Analysis to 2025” is a specialized and in-depth study of the medical device industry with a focus on the global market trend. The report aims to provide an overview of global artificial pancreas device system market with detailed market segmentation by type, and geography. The global artificial pancreas device system market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading market players and offers key trends and opportunities in the market.
Top Dominating Key Players: 1. Defymed 2. Beta Bionics 3. TypeZero Technologies, Inc. 4. Tandem Diabetes Care, Inc. 5. BIGFOOT BIOMEDICAL, INC. 6. Johnson & Johnson Services, Inc. 7. Pancreum, Inc. 8. Medtronic 9. Insulet Corporation 10. Admetsys
The artificial pancreas device system market is expected to grow significantly due to the key factors such as rise in the number of diabetes incidences in growing geriatric population as well as in the young age people, increase in the technological advancement and also the support from the FDA raises the medical innovations to produce safe and effective devices for the medical industries. For instances, in October 2016, FDA approved the first hybrid closed loop system known as MiniMed 670G system of Medtronics. Thus, these factors are motivating the players to produce more devices with more advanced technology which will eventually lead to the market growth of artificial pancreas device system in future.
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global artificial pancreas device system market based on type. It also provides market size and forecast till 2025 for overall artificial pancreas device system market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 13 counties globally along with current trend and opportunities prevailing in the region.
Artificial Pancreas Device System Market report aims to provide a 360-degree view of the market in terms of cutting-edge technology, key developments, drivers, restraints and future trends with impact analysis of these trends on the market for short-term, mid-term and long-term during the forecast period. Further, the report also covers key players profiling with detailed SWOT analysis, financial facts and key developments of products/service from the past three years.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including: